Invention Grant
US08541380B2 C-aryl glucoside SGLT2 inhibitors and pharmaceutical compositions comprising same
有权
C-芳基葡糖苷SGLT2抑制剂和包含其的药物组合物
- Patent Title: C-aryl glucoside SGLT2 inhibitors and pharmaceutical compositions comprising same
- Patent Title (中): C-芳基葡糖苷SGLT2抑制剂和包含其的药物组合物
-
Application No.: US13379301Application Date: 2010-06-18
-
Publication No.: US08541380B2Publication Date: 2013-09-24
- Inventor: Jinhwa Lee , Suk Ho Lee , Hee Jeong Seo , Min Ju Kim , Suk Youn Kang , Jeongmin Kim , Sung-Han Lee , Myung Eun Jung , Eun Jung Son , Kwang-Seop Song , Mi-Soon Kim
- Applicant: Jinhwa Lee , Suk Ho Lee , Hee Jeong Seo , Min Ju Kim , Suk Youn Kang , Jeongmin Kim , Sung-Han Lee , Myung Eun Jung , Eun Jung Son , Kwang-Seop Song , Mi-Soon Kim
- Applicant Address: KR Yongin-si
- Assignee: Green Cross Corporation
- Current Assignee: Green Cross Corporation
- Current Assignee Address: KR Yongin-si
- Agency: Sughrue Mion, PLLC
- International Application: PCT/KR2010/003958 WO 20100618
- International Announcement: WO2010/147430 WO 20101223
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70 ; C07H1/00 ; C07H5/04
Abstract:
A novel C-aryl glucoside compound, or a pharmaceutically acceptable salt or a prodrug thereof having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney; and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly, diabetes, are provided.
Public/Granted literature
- US20120101051A1 NOVEL C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME Public/Granted day:2012-04-26
Information query
IPC分类:
